The 12th Annual ImVacS: The Immunotherapies and Vaccines Summit 2017 covers topics such as:
- Novel Vaccines: Emerging Vaccine Technologies
- Novel Vaccines: Adjuvants, TLRs & DNA Vaccines
- Combination Cancer Immunotherapy
- Immunomodulatory Therapeutic Antibodies for Cancer
- The Regulatory Outlook for Future Vaccine Adjuvants
- Target Discovery for T Cell Therapy
- Putting Cancer in Check with Novel Immunomodulatory Strategies
- Synthetic Genomics to Address Emerging Threats and Global Supply Challenges
- Clinical Trials for Immunotherapy Combinations
The 12th Annual ImVacS: The Immunotherapies and Vaccines Summit 2017 brings together vaccine researchers and developers of cancer immunotherapies.
